These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 23592749)

  • 21. Decreased cellular uptake and metabolism in Allan-Herndon-Dudley syndrome (AHDS) due to a novel mutation in the MCT8 thyroid hormone transporter.
    Maranduba CM; Friesema EC; Kok F; Kester MH; Jansen J; Sertié AL; Passos-Bueno MR; Visser TJ
    J Med Genet; 2006 May; 43(5):457-60. PubMed ID: 15980113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thyroid hormone transporters--functions and clinical implications.
    Bernal J; Guadaño-Ferraz A; Morte B
    Nat Rev Endocrinol; 2015 Jul; 11(7):406-17. PubMed ID: 25942657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thyroid hormone transport by monocarboxylate transporters.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Best Pract Res Clin Endocrinol Metab; 2007 Jun; 21(2):223-36. PubMed ID: 17574005
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional analysis of monocarboxylate transporter 8 mutations in Japanese Allan-Herndon-Dudley syndrome patients.
    Islam MS; Namba N; Ohata Y; Fujiwara M; Nakano C; Takeyari S; Miyata K; Nakano Y; Yamamoto K; Nakayama H; Kitaoka T; Kubota T; Ozono K
    Endocr J; 2019 Jan; 66(1):19-29. PubMed ID: 30369548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid hormone cell membrane transport defect.
    Ramos HE
    Endocr Dev; 2014; 26():108-17. PubMed ID: 25231447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular aspects of thyroid hormone transporters, including MCT8, MCT10, and OATPs, and the effects of genetic variation in these transporters.
    van der Deure WM; Peeters RP; Visser TJ
    J Mol Endocrinol; 2010 Jan; 44(1):1-11. PubMed ID: 19541799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid hormone transporters.
    Friesema EC; Jansen J; Milici C; Visser TJ
    Vitam Horm; 2005; 70():137-67. PubMed ID: 15727804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid hormone transport by the human monocarboxylate transporter 8 and its rate-limiting role in intracellular metabolism.
    Friesema EC; Kuiper GG; Jansen J; Visser TJ; Kester MH
    Mol Endocrinol; 2006 Nov; 20(11):2761-72. PubMed ID: 16887882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role and Clinical Significance of Monocarboxylate Transporter 8 (MCT8) During Pregnancy.
    Thomas J; Sairoz ; Jose A; Poojari VG; Shetty S; K SP; Prabhu R V K; Rao M
    Reprod Sci; 2023 Jun; 30(6):1758-1769. PubMed ID: 36595209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of monocarboxylate transporter 8 oligomerization by specific pathogenic mutations.
    Fischer J; Kleinau G; Müller A; Kühnen P; Zwanziger D; Kinne A; Rehders M; Moeller LC; Führer D; Grüters A; Krude H; Brix K; Biebermann H
    J Mol Endocrinol; 2015 Feb; 54(1):39-50. PubMed ID: 25527620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thyroid hormone transporters in health and disease.
    Jansen J; Friesema EC; Milici C; Visser TJ
    Thyroid; 2005 Aug; 15(8):757-68. PubMed ID: 16131319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and functional characterization of zebrafish solute carrier Slc16a2 (Mct8) as a thyroid hormone membrane transporter.
    Arjona FJ; de Vrieze E; Visser TJ; Flik G; Klaren PH
    Endocrinology; 2011 Dec; 152(12):5065-73. PubMed ID: 21952246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming Monocarboxylate Transporter 8 (MCT8)-Deficiency to Promote Human Oligodendrocyte Differentiation and Myelination.
    Lee JY; Kim MJ; Deliyanti D; Azari MF; Rossello F; Costin A; Ramm G; Stanley EG; Elefanty AG; Wilkinson-Berka JL; Petratos S
    EBioMedicine; 2017 Nov; 25():122-135. PubMed ID: 29111262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel pathogenic mechanism suggested by ex vivo analysis of MCT8 (SLC16A2) mutations.
    Visser WE; Jansen J; Friesema EC; Kester MH; Mancilla E; Lundgren J; van der Knaap MS; Lunsing RJ; Brouwer OF; Visser TJ
    Hum Mutat; 2009 Jan; 30(1):29-38. PubMed ID: 18636565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid hormone transporters.
    Visser TJ
    Horm Res; 2007; 68 Suppl 5():28-30. PubMed ID: 18174701
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Groeneweg S; Kersseboom S; van den Berge A; Dolcetta-Capuzzo A; van Geest FS; van Heerebeek REA; Arjona FJ; Meima ME; Peeters RP; Visser WE; Visser TJ
    Thyroid; 2019 Oct; 29(10):1499-1510. PubMed ID: 31436139
    [No Abstract]   [Full Text] [Related]  

  • 37. Thyroid hormone transport in and out of cells.
    Visser WE; Friesema EC; Jansen J; Visser TJ
    Trends Endocrinol Metab; 2008 Mar; 19(2):50-6. PubMed ID: 18291666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of cysteine residues in the thyroid hormone transporter MCT8.
    Lima de Souza EC; Groeneweg S; Visser WE; Peeters RP; Visser TJ
    Endocrinology; 2013 May; 154(5):1948-55. PubMed ID: 23546606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling the Biochemical Phenotype of MCT8 Mutations In Vitro: Resolving a Troubling Inconsistency.
    Braun D; Reuter U; Schweizer U
    Endocrinology; 2019 Jun; 160(6):1536-1546. PubMed ID: 31127274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MCT8 mutation analysis and identification of the first female with Allan-Herndon-Dudley syndrome due to loss of MCT8 expression.
    Frints SG; Lenzner S; Bauters M; Jensen LR; Van Esch H; des Portes V; Moog U; Macville MV; van Roozendaal K; Schrander-Stumpel CT; Tzschach A; Marynen P; Fryns JP; Hamel B; van Bokhoven H; Chelly J; Beldjord C; Turner G; Gecz J; Moraine C; Raynaud M; Ropers HH; Froyen G; Kuss AW
    Eur J Hum Genet; 2008 Sep; 16(9):1029-37. PubMed ID: 18398436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.